Sign in

CIK 0001826457

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Monte Rosa Therapeutics, Inc.

Sign in to watch
Ticker
GLUE
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2643
Business address
321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
Former names
Monte Rosa Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$137
in 1 filing

Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Bowen Matthew −$137 Principal Accounting Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-06-29 Manning Anthony M. Director Exercise or conversion +10,000 $4.16 $42K 10,000
2026-06-29 Manning Anthony M. Director Sale −10,000 $23.11 $231K 0
2026-06-29 Manning Anthony M. Director Exercise or conversion · Stock Option (Right to Buy) −10,000 2,100
2026-06-11 Manning Anthony M. Director Grant or award · Stock Option (Right to Buy) +25,800 25,800
2026-05-21 Manning Anthony M. Director Exercise or conversion +10,000 $4.16 $42K 10,000
2026-05-21 Manning Anthony M. Director Sale −10,000 $18.01 $180K 0
2026-05-21 Manning Anthony M. Director Exercise or conversion · Stock Option (Right to Buy) −10,000 12,100
2025-06-13 Manning Anthony M. Director Grant or award · Stock Option (Right to Buy) +30,700 30,700
2024-06-12 Manning Anthony M. Director Grant or award · Stock Option (Right to Buy) +22,100 22,100
2023-07-25 Manning Anthony M. Director Grant or award · Stock Option (Right to Buy) +41,000 41,000

Page 1 of 1 · 10 trades